Abstract
In this issue of Blood, Berger et al present a longitudinal study of the clonal trajectory of preleukemic mutations in patients who developed therapy-related myeloid neoplasms (t-MNs) after autologous stem-cell transplantation. The authors show that t-MN driver mutations are often detectable as clonal hematopoiesis of indeterminate potential (CHIP) many years before patients develop t-MNs, and they demonstrate complicated patterns of clonal expansion and evolution over time, leading to the development of t-MNs.1
Original language | English (US) |
---|---|
Pages (from-to) | 1773-1774 |
Number of pages | 2 |
Journal | Blood |
Volume | 131 |
Issue number | 16 |
DOIs | |
State | Published - Apr 19 2018 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology